Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials

被引：0
|
作者：
Chris H. Takimoto
Ahmad Awada
机构：
[1] South Texas Accelerated Research Therapeutics (START),Medical Oncology Clinic
[2] Jules Bordet Institute,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Combination; Chemotherapy; Phase I/II clinical trials; Solid tumors; Sorafenib; Targeted agent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：535 / 548
页数：13
相关论文
共 50 条
  • [21] Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia
    Candida Vitale
    Valentina Griggio
    Maria Todaro
    Chiara Riganti
    Rebecca Jones
    Elia Boccellato
    Francesca Perutelli
    Francesca Arruga
    Tiziana Vaisitti
    Dimitar G. Efremov
    Silvia Deaglio
    Yosef Landesman
    Benedetto Bruno
    Marta Coscia
    Scientific Reports, 13
  • [22] Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia
    Vitale, Candida
    Griggio, Valentina
    Todaro, Maria
    Riganti, Chiara
    Jones, Rebecca
    Boccellato, Elia
    Perutelli, Francesca
    Arruga, Francesca
    Vaisitti, Tiziana
    Efremov, Dimitar G.
    Deaglio, Silvia
    Landesman, Yosef
    Bruno, Benedetto
    Coscia, Marta
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [23] Modulation of APC function and anti-tumor immunity by anti-cancer drugs
    Martin, Kea
    Schreiner, Jens
    Zippelius, Alfred
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [24] Anti-Tumor Activity of Indole: A Review
    Mohamed, Momen R. F.
    Shoman, Mai E.
    Ali, Taha F. S.
    Abuo-Rahma, Gamal El-Din A.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (16) : 3332 - 3348
  • [25] Enhanced anti-tumor effects of TP300, a novel camptothecin analogue, in combination with other anti-tumor agents in human tumor xenograft models
    Endo, M.
    Ura, M.
    Tanimura, H.
    Taniguchi, K.
    Miyazaki, Y.
    Nagao, S.
    Okabe, H.
    Miwa, M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 186 - 186
  • [26] Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma
    Nagel, Carmen
    Armeanu-Ebinger, Sorin
    Dewerth, Alexander
    Warmann, Steven W.
    Fuchs, Joerg
    EXPERIMENTAL CELL RESEARCH, 2015, 331 (01) : 97 - 104
  • [27] SAFETY OF ANTI-TUMOR NECROSIS AGENTS IN PATIENTS WITH CIRRHOSIS
    Kapila, Nikhil
    Melendez-Rosado, Jose
    Flocco, Gianina
    Salomon, Fayssa
    Sojo, Paul
    Esfeh, Jamak Modaresi
    Castro, Fernando
    GASTROENTEROLOGY, 2019, 156 (06) : S1204 - S1204
  • [28] Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety
    Adler, Brandon L.
    Wang, Catherine J.
    Thanh-Lan Bui
    Schilperoort, Hannah M.
    Armstrong, April W.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1093 - 1104
  • [29] IN THE SEARCH FOR NEW ANTI-CANCER DRUGS .4. ANTI-TUMOR ACTIVITY OF SELENO-TEPA
    KONIECZNY, M
    GUTIERREZ, PL
    SOSNOVSKY, G
    ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 1983, 38 (09): : 1138 - 1141
  • [30] ANTI-CANCER AGENTS AND ANTITRYPANOSOMIASIS ACTIVITY IN MICE
    KINNAMON, KE
    STECK, EA
    RANE, DS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1980, 64 (02) : 391 - 394
12345